Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 2, 2010, Pages 293-300

  Dean, Olivia ^a,b   Bush, Ashley I ^a   Berk, Michael ^b,c   Copolov, David L ^d   van den Buuse, Maarten ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Amphetamine; Glutathione; MK 801; Prepulse inhibition; Schizophrenia; Startle

Indexed keywords

2 CYCLOHEXENONE; DEXAMPHETAMINE; DIZOCILPINE; DOPAMINE; GLUTATHIONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; FRONTAL CORTEX; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STARTLE REFLEX;

ACOUSTIC STIMULATION; AMPHETAMINE; ANIMALS; BRAIN CHEMISTRY; CYCLOHEXANONES; DIZOCILPINE MALEATE; DOPAMINE AGENTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTATHIONE; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICE; MICE, INBRED C57BL; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY GATING; STARTLE REACTION;

MUS; RATTUS;

EID: 77957823232     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.08.013     Document Type: Article

References (49)

1. Agarwal R., Shukla G.S. Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem Res 1999, 24:1507-1514.
2. Baker M.A., Cerniglia G.J., Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990, 190:360-365.
3. Bashkatova V., Mathieu-Kia A.M., Durand C., Penit-Soria J. Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant: comparison with D-amphetamine. Ann N Y Acad Sci 2002, 965:180-192.
4. Bast T., Zhang W., Feldon J., White I.M. Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats. Pharmacol Biochem Behav 2000, 67:647-658.
5. Benzi G., Curti D., Marzatico F., Pastoris O. Age-related acute depletion of cerebral glutathione by peroxidative stress. Journal of Neuroscience Research 1991, 29:527-532.
6. Berk M., Copolov D., Dean O., Lu K., Jeavons S., Schapkaitz I., et al. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 2008, 64:361-368.
7. Bondy S.C., Guo S.X. Effect of an NMDA receptor antagonist and a ganglioside GM1 derivative upon ethanol-induced modification of parameters of oxidative stress in several brain regions. Brain Res 1996, 716:165-170.
8. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 1990, 47:181-188.
9. Bubenikova V., Votava M., Horacek J., Palenicek T., Dockery C. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol Biochem Behav 2005, 80:591-596.
10. Castro A.A., Moretti M., Casagrande T.S., Martinello C., Petronilho F., Steckert A.V., et al. Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. Pharmacol Biochem Behav 2009, 91:636-642.
11. Chavez C., Gogos A., Jones M.E., van den Buuse M. Psychotropic drug-induced locomotor hyperactivity and prepulse inhibition regulation in male and female aromatase knockout (ArKO) mice: role of dopamine D1 and D2 receptors and dopamine transporters. Psychopharmacology (Berl) 2009, 206:267-279.
12. Choy K.H., de Visser Y.P., van den Buuse M. The effect of 'two hit' neonatal and young-adult stress on dopaminergic modulation of prepulse inhibition and dopamine receptor density. Br J Pharmacol 2009, 156:388-396.
13. Choy K.H., van den Buuse M. Attenuated disruption of prepulse inhibition by dopaminergic stimulation after maternal deprivation and adolescent corticosterone treatment in rats. Eur Neuropsychopharmacol 2008, 18:1-13.
14. Dai H., Okuda H., Iwabuchi K., Sakurai E., Chen Z., Kato M., et al. Social isolation stress significantly enhanced the disruption of prepulse inhibition in mice repeatedly treated with methamphetamine. Ann N Y Acad Sci 2004, 1025:257-266.
15. Dean O., Bush A.I., Berk M., Copolov D.L., van den Buuse M. Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice. Behav Brain Res 2009, 198:258-262.
16. Dean O.M., van den Buuse M., Bush A.I., Copolov D.L., Ng F., Dodd S., et al. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 2009, 16:2965-2976.
17. Do K.Q., Trabensinger M.K., Lauer C.J., Dydak U., Hell D., Holsboer F., et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 2000, 12:3721-3728.
18. Dringen R., Hirrlinger J. Glutathione pathways in the brain. Biol Chem 2003, 384:505-516.
19. Druhan J.P., Geyer M.A., Valentino R.J. Lack of sensitization to the effects of d-amphetamine and apomorphine on sensorimotor gating in rats. Psychopharmacology (Berl) 1998, 135:296-304.
20. Filloux F., Townsend J.J. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 1993, 119:79-88.
21. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007, 47:681-698.
22. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., et al. Changes in Antioxidant Defense Enzymes after D-: amphetamine Exposure: Implications as an Animal Model of Mania. Neurochem Res 2006, 31:699-703.
23. Geyer M.A. and NR Swerdlow. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001, 156:117-154.
24. Gogos A., Bogeski M., van den Buuse M. Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behav Pharmacol 2008, 19:548-561.
25. Graham D.G., Tiffany S.M., Bell W.R., Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 1978, 14:644-653.
26. Hoyt K.R., Reynolds I.J., Hastings T.G. Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp Neurol 1997, 143:269-281.
27. Jacobsen J.P., Rodriguiz R.M., Mork A., Wetsel W.C. Monoaminergic dysregulation in glutathione-deficient mice: Possible relevance to schizophrenia?. Neuroscience 2005, 132:1055-1072.
28. Jiang D., Akopian G., Ho Y.S., Walsh J.P., Andersen J.K. Chronic brain oxidation in a glutathione peroxidase knockout mouse model results in increased resistance to induced epileptic seizures. Exp Neurol 2000, 164:257-268.
29. Keith V.A., Mansbach R.S., Geyer M.A. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 1991, 30:557-566.
30. Khan M., Sekhon B., Jatana M., Giri S., Gilg A.G., Sekhon C., et al. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res 2004, 76:519-527.
31. Kusljic S., Brosda J., Norman T.R., van den Buuse M. Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats. Brain Res 2005, 1049:217-226.
32. Masukawa T., Sai M., Tochino Y. Methods for depleting brain glutathione. Life Sci 1989, 44:417-424.
33. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994, 54:1969s-1975s.
34. Moore H., West A.R., Grace A.A. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 1999, 46:40-55.
35. Murphy C.A., Fend M., Russig H., Feldon J. Latent inhibition, but not prepulse inhibition, is reduced during withdrawal from an escalating dosage schedule of amphetamine. Behav Neurosci 2001, 115:1247-1256.
36. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 2008, 1-26.
37. Ogita K., Kitago T., Nakamuta H., Fukuda Y., Koida M., Ogawa Y., et al. Glutathione-induced inhibition of Na+-independent and -dependent bindings of L-[3H]glutamate in rat brain. Life Sci 1986, 39:2411-2418.
38. Ozyurt B., Sarsilmaz M., Akpolat N., Ozyurt H., Akyol O., Herken H., et al. The protective effects of omega-3 fatty acids against MK-801-induced neurotoxicity in prefrontal cortex of rat. Neurochem Int 2007, 50:196-202.
39. Ralph-Williams R.J., Lehmann-Masten V., Otero-Corchon V., Low M.J., Geyer M.A. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J Neurosci 2002, 22:9604-9611.
40. Steullet P., Neijt H.C., Cuenod M., Do K.Q. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia. Neuroscience 2006, 137:807-819.
41. Valvassori S.S., Moretti M., Kauer-Sant'Anna M., Roesler R., Petronilho F., Schwartsmann G., et al. Effects of a gastrin-releasing peptide receptor antagonist on D-amphetamine-induced oxidative stress in the rat brain. J Neural Transm 2010, 117:309-316.
42. M van den Buuse Deficient prepulse inhibition of acoustic startle in Hooded-Wistar rats compared with Sprague-Dawley rats. Clin Exp Pharmacol Physiol 2003, 30:254-261.
43. van den Buuse M., Eikelis N. Estrogen increases prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 2001, 425:33-41.
44. van den Buuse M., Garner B., Gogos A., Kusljic S. Importance of animal models in schizophrenia research. Aust N Z J Psychiatry 2005, 39:550-557.
45. Varga V., Jenei Z., Janaky R., Saransaari P., Oja S.S. Glutathione is an endogenous ligand of rat brain N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors. Neurochem Res 1997, 22:1165-1171.
46. Varty G.B., Walters N., Cohen-Williams M., Carey G.J. Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur J Pharmacol 2001, 424:27-36.
47. Wan F.J., Swerdlow N.R. Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions. Brain Res 1996, 722:168-176.
48. Wan F.J., Lin H.C., Huang K.L., Tseng C.J., Wong C.S. Systemic administration of d-amphetamine induces long-lasting oxidative stress in the rat striatum. Life Sci 2000, 66:PL205-PL212.
49. Yao J.K., Leonard S., Reddy R. Altered glutathione redox state in schizophrenia. Dis Markers 2006, 22:83-93.